Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

Nordic Capital, Astorg jointly acquire Cytel

, 27 January 2021/in E-News /by 3wmedia

Nordic Capital and Astorg have jointly acquired acquire Cytel Inc. from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and biometrics execution.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:15:102021-01-29 01:22:41Nordic Capital, Astorg jointly acquire Cytel
2 E NEWS LSBIO

LSBio acquires Absolute Antibody

, 27 January 2021/in E-News /by 3wmedia

Seattle, US-based LSBio, a leading provider of antibodies and life science research reagents, has acquired UK-based Absolute Antibody and its sister company Kerafast. Terms of the transaction were not disclosed.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/2_E-NEWS_LSBIO.jpg 521 690 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:13:192021-01-29 01:22:41LSBio acquires Absolute Antibody

European Commission’s Open Research Europe platform up and running

, 27 January 2021/in E-News /by 3wmedia

The new Open Research Europe (ORE) platform – funded by the European Commission – is now up and running.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:12:012021-01-29 01:22:42European Commission’s Open Research Europe platform up and running
3 E NEWS OVARIAN

Ovarian cancer project shows promise

, 27 January 2021/in E-News /by 3wmedia

Due to promising results, Porvair Sciences has agreed with its collaborative partners to make additional investment in the CEAT project which aims to dramatically improve the diagnosis and treatment of ovarian cancer.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/3_E-NEWS_OVARIAN.jpg 575 1000 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:10:082021-01-29 01:22:42Ovarian cancer project shows promise
4 E NEWS MOGRIFY

Mogrify secures IP foundational to its cell conversion technology

, 27 January 2021/in E-News /by 3wmedia

UK-based Mogrify has secured the assignment of the foundational intellectual property (IP) underpinning its core direct cell conversion technology (Mogrify V1) and extended the method to allow for the inclusion of new sources of data and more accurate transcription factor predictions (Mogrify V2). The expansion of rights allows the Company to bring the latest version […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/4_E-NEWS_MOGRIFY.jpg 995 676 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:06:382021-01-29 01:22:42Mogrify secures IP foundational to its cell conversion technology

Novigenix-led consortium secures Eurostars funding to develop predictive immune checkpoint inhibitor test

, 27 January 2021/in E-News /by 3wmedia

Novigenix SA Switzerland, a pioneer in immuno-transcriptomics for precision medicine, will lead a consortium, including PamGene International and Radboud University (The Netherlands), to develop a blood based multi-omics test to predict response to immune checkpoint inhibitors in cancer. The consortium has been awarded a grant up to €1 million under the Eurostars programme.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:04:492021-01-29 01:22:43Novigenix-led consortium secures Eurostars funding to develop predictive immune checkpoint inhibitor test
5 E NEWS PEPSCOPE

Pepscope secures investment to boost development kinase inhibitor therapies

, 27 January 2021/in E-News /by 3wmedia

Dutch biotech company Pepscope, offering endogenous protein kinase activity profiling technologies, has secured €4.3 million funding to further develop and commercialize their lead product QuantaKinome.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/5_E-NEWS_PEPSCOPE.jpg 415 675 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:03:332021-01-29 01:22:43Pepscope secures investment to boost development kinase inhibitor therapies
6 E NEWS RETINAI

RetinAI to provide AI solutions for Novartis ophthalmology research

, 27 January 2021/in E-News /by 3wmedia

Switzerland-based RetinAI Medical will collaborate with Novartis Pharma in a multi-year agreement which will see RetinAI’s artificial intelligence tools employed to support multiple projects in ophthalmology. Both companies have previously worked successfully on pilot projects in this disease area.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/6_E-NEWS_RETINAI.jpg 581 676 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:02:152021-01-29 01:22:43RetinAI to provide AI solutions for Novartis ophthalmology research

SYNLAB sells Analytics & Services unit

, 27 January 2021/in E-News /by 3wmedia

SYNLAB, the leading medical diagnostic services provider in Europe, has agreed to sell its Analytics & Services (A&S) unit to SGS, the world’s leading inspection, verification, testing and certification company. The proceeds of the sale will remain in the group for future use.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 01:01:022021-01-29 01:22:43SYNLAB sells Analytics & Services unit
7 E NEWS FLUORESCENE MICROSCOPY

Comb of a lifetime: a new method for fluorescence microscopy

, 27 January 2021/in E-News /by 3wmedia

Fluorescence microscopy is widely used in biochemistry and life sciences because it allows scientists to directly observe cells and certain compounds in and around them. Fluorescent molecules absorb light within a specific wavelength range and then re-emit it at the longer wavelength range. However, the major limitation of conventional fluorescence microscopy techniques is that the […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2021/01/7_E-NEWS_FLUORESCENE_MICROSCOPY.jpg 354 694 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2021-01-27 00:51:462021-01-29 01:22:44Comb of a lifetime: a new method for fluorescence microscopy
Page 73 of 227«‹7172737475›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription